Browsing by Publisher "Taylor & Francis Inc."
Now showing items 1-4 of 4
-
Erbium:yttrium aluminum garnet laser versus Q-switched neodymium: yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum
(Taylor & Francis Inc., 2017)Background: Several lasers have been used for the treatment of xanthelasma palpebrarum (XP), such as Q-switched neodymium: yttrium aluminum garnet (QSNd: YAG) and erbium: yttrium aluminum garnet (Er: YAG) laser. Up to now, ... -
Is change in hemoglobin level a predictive biomarker of tyrosine kinase efficacy in metastatic renal cell carcinoma? A Turkish oncology group study
(Taylor & Francis Inc., 2017)Background: There are insufficient predictive markers for renal cell carcinoma (RCC). Methods: A total of 308 metastatic RCC patients were analyzed retrospectively. Results: The increased hemoglobin (Hb) group had significantly ... -
Noun and verb knowledge in monolingual preschool children across 17 languages: Data from Cross-linguistic Lexical Tasks (LITMUS-CLT)
(Taylor & Francis Inc., 2017)This article investigates the cross-linguistic comparability of the newly developed lexical assessment tool Cross-linguistic Lexical Tasks (LITMUS-CLT). LITMUS-CLT is a part the Language Impairment Testing in Multilingual ... -
Prostaglandin E2 levels of aqueous and vitreous humor in ketorolac 0.4% and nepafenac 0.1% administered healthy rabbits
(Taylor & Francis Inc., 2017)Purpose: To compare the lowering effects of ketorolac 0.4% and nepafenac 0.1% on aqueous and vitreous humor prostaglandin E-2 (PGE(2)) levels in rabbits.Methods: Ketorolac and nepafenac ophthalmic solutions were administered ...
